A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulin-Reference-Cited by-同舟云学术

A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulin

Published:2012-12-31 Issue:8 Volume:54 Page:1713-1718
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Larsen Jeremy T.,Hogan William J.,Micallef Ivana N.,Dispenzieri Angela,Gertz Morie A.,Inwards David J.,Tun Han W.,Roy Vivek,Geyer Susan M.,Allred Jacob B.,Wu Wenting,Ansell Stephen M.,Elliott Michelle A.,Tefferi Ayalew,Porrata Luis F.,Gastineau Dennis A.,Lacy Martha Q.,Litzow Mark R.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2012.753444

Reference22 articles.

1. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009

2. Effects of Irradiation and Antigenic Stimulation on Circulating Haemopoietic Stem Cells of the Mouse

3. Antileukemic Effect of Chronic Graft-versus-Host Disease

4. Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases

5. Hematopoietic stem cell therapy for malignant diseases

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incorporation of thiotepa in a reduced intensity conditioning regimen may improve engraftment after transplant for HLH;British Journal of Haematology;2020-01-27